Tocagen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Tocagen and buy or sell other stocks, ETFs, and their options commission-free!

About TOCA

Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer. It is in the business of discovery, development, and commercialization of products for the treatment of cancer. 

CEO
Martin J. Duvall, MBA
CEOMartin J. Duvall, MBA
Employees
14
Employees14
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2007
Founded2007
Employees
14
Employees14

TOCA Key Statistics

Market cap
223.32M
Market cap223.32M
Price-Earnings ratio
-0.57
Price-Earnings ratio-0.57
Dividend yield
Dividend yield
Average volume
17.34K
Average volume17.34K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$28.68
52 Week high$28.68
52 Week low
$4.11
52 Week low$4.11

People also own

Based on the portfolios of people who own TOCA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.